JamesDBerryMD

Neurology • Boston, MA

Neuromuscular Medicine

Instructor, Neurology, Massachusetts General Hospital, Harvard Medical School

Join to view full profile

Dr. Berry is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Berry's full profile

Already have an account?

Office
55 Fruit St Fl 8
Boston, MA 02114
Phone+1 617-724-3914
Is this information wrong?

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2006 - 2009
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 2005 - 2006
Northwestern University The Feinberg School of MedicineClass of 2005

Certifications & Licensure

MA State Medical License 2009 - 2025
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Neuromuscular Medicine

Clinical Trials

A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers Start of enrollment: 2011 Nov 01
Completed
Gilenya in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Completed
Phase 2
Longitudinal Study of Outcomes Measures in ALS Trials Start of enrollment: 2013 Jul 01
Completed
Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Completed
Phase 2
Phase 2, Randomized, Double Blind, Placebo Controlled Multicenter Study of Autologous MSC-NTF Cells in Patients With ALS Start of enrollment: 2014 May 01
Completed
Phase 2
Open Label Extension Study of AMX0035 in Patients With ALS Start of enrollment: 2018 Mar 29
Completed
Phase 2
T-regulatory Cells in ALS Start of enrollment: 2019 Aug 07
Active, not recruiting
Phase 2
RAPA-501 Therapy for ALS Start of enrollment: 2020 Dec 15
Recruiting
Phase 2, Phase 3
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP) Start of enrollment: 2021 Oct 15
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Longitudinal comparison of the self-administered ALSFRS-RSE and ALSFRS-R as functional outcome measures in ALS.
M Kelley Erb, Narghes Calcagno, Roland Brown, Katherine M Burke, Zoe A Scheier, Amrita S Iyer, Alison Clark, Max P Higgins, Mackenzie Keegan, Anoopum S Gupta, Stephen ...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 Mar 19
1 citations
Upper limb movements as digital biomarkers in people with ALS.
Marcin Straczkiewicz, Marta Karas, Stephen A Johnson, Katherine M Burke, Zoe Scheier, Tim B Royse, Narghes Calcagno, Alison Clark, Amrita Iyer, James D Berry, Jukka-Pe...> ;Ebiomedicine. 2024 Mar 1
The ALSFRS-R Summit: a global call to action on the use of the ALSFRS-R in ALS clinical trials.
Angela Genge, Jesse M Cedarbaum, Jeremy Shefner, Adriano Chio, Ammar Al-Chalabi, Philip Van Damme, Chris McDermott, Jonathan Glass, James Berry, Ruben P A van Eijk, Ch...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2024 May 1
The Intense Psychological Burden of ALS, the Enduring Strength of People Living With ALS, and the Tools We Can Use to Help.
Ho, D., Berry, J.> ;The Journal of Clinical Psychiatry. 2023 Dec 13
Identifying amyotrophic lateral sclerosis through interactions with an internet search engine.
Elad Yom-Tov, Indu Navar, Ernest Fraenkel, James D Berry> ;Muscle & Nerve. 2024 Jan 1
Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Angela Genge, Leonard H van den Berg, Glen Frick, Steve Han, Cori Abikoff, Adam Simmons, Qun Lin, Kaushik Patra, Erik Kupperman, James D Berry> ;JAMA Neurology. 2023 Oct 1
Comparing Amyotrophic lateral sclerosis (ALS) patient characteristics from the National ALS Registry and the Massachusetts ALS Registry, data through 2015.
Jaime Raymond, Reshma Punjani, Theodore Larson, James D Berry, D Kevin Horton, Paul Mehta> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Aug 4
Amyotrophic Lateral Sclerosis-Bulbar Dysfunction Index-Remote: Test-Retest and Interrater Reliability of Candidate Items.
Liziane Bouvier, Jordan R Green, Carolina Barnett Tapia, Victoria Tilton-Bolowsky, Marc F Maffei, Zuzana Fless, Katie Seaver, Anna Huynh, Sarah E Gutz, Rosemary Martin...> ;American Journal of Speech-Language Pathology. 2023 Aug 17
Resilient together-ALS: leveraging the NDD transdiagnostic framework to develop an early dyadic intervention for people with amyotrophic lateral sclerosis and their in...
Christina L Rush, Ethan G Lester, Heena Manglani, Emily Woodworth, Ottavio Vitolo, Maurizio Fava, James D Berry, Kate Brizzi, Suma Babu, Elizabeth C Lindenberger, J Ra...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Jun 22
2 citations
Design and Statistical Innovations in a Platform Trial for Amyotrophic Lateral Sclerosis.
Melanie Quintana, Benjamin R Saville, Matteo Vestrucci, Michelle A Detry, Lori Chibnik, Jeremy Shefner, James D Berry, Marianne Chase, Jinsy Andrews, Alexander V Sherm...> ;Annals of Neurology. 2023 Sep 1
1 citations
A roadmap for early psychosocial support in palliative care for people impacted by ALS-reducing suffering, building resiliency, and setting the stage for delivering ti...
Christina L Rush, Ethan G Lester, James D Berry, Kate T Brizzi, Elizabeth C Lindenberger, Jared Randall Curtis, Ana-Maria Vranceanu> ;Translational Behavioral Medicine. 2023 Sep 12
1 citations
Expanded access protocol (EAP) program for access to investigational products for amyotrophic lateral sclerosis (ALS).
Megan Yerton, Allison Winter, Dario Gelevski, Grace Addy, Anthony Kostov, Cassandra Lieberman, Harli Weber, Michael Doyle, Geli Kane, Caroline Cohen, Neil Parikh, Kath...> ;Muscle & Nerve. 2023 Jun 1
5 citations
Wearable device and smartphone data quantify ALS progression and may provide novel outcome measures.
Stephen A Johnson, Marta Karas, Katherine M Burke, Marcin Straczkiewicz, Zoe A Scheier, Alison P Clark, Satoshi Iwasaki, Amir Lahav, Amrita S Iyer, Jukka-Pekka Onnela,...> ;NPJ Digital Medicine. 2023 Mar 6
4 citations
Randomized trial of inosine for urate elevation in amyotrophic lateral sclerosis.
David Walk, Katharine Nicholson, Eduardo Locatelli, James Chan, Eric A Macklin, Valerie Ferment, Georgios Manousakis, Marianne Chase, Mariah Connolly, Derek Dagostino,...> ;Muscle & Nerve. 2023 May 1
Acoustic Measures of Dysphonia in Amyotrophic Lateral Sclerosis.
Marc F Maffei, Jordan R Green, Olivia Murton, Yana Yunusova, Hannah P Rowe, Farah Wehbe, Kathleen Diana, Katharine Nicholson, James D Berry, Kathryn P Connaghan> ;Journal of Speech, Language, and Hearing Research. 2023 Mar 7
3 citations
Epidemiology and economic burden of amyotrophic lateral sclerosis in the United States: a literature review.
James D Berry, Marie Blanchard, Kerina Bonar, Emma Drane, Molly Murton, Uffe Ploug, Kristen Ricchetti-Masterson, Natasa Savic, Emma Worthington, Terry Heiman-Patterson> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 Aug 1
Targeting amyotrophic lateral sclerosis by neutralizing seeding-competent TDP-43 in CSF.
Audrain, M., Egesipe, A., Tentillier, N., Font, L., Ratnam, M., Mottier, L., Clavel, M., Le Roux-Bourdieu, M., Fenyi, A., Ollier, R., Chevalier, E., Guilhot, F., Fuchs...> ;Brain Communications. 2023 Jan 1
1 citations
Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: Experience with expanded access protocol.
Dario Gelevski, Grace Addy, Margot Rohrer, Caroline Cohen, Aimee Roderick, Allison Winter, Judith Carey, Jennifer Scalia, Megan Yerton, Harli Weber, Michael Doyle, Nei...> ;Muscle & Nerve. 2023 May 1
2 citations
Comprehensive evaluation of human-derived anti-poly-GA antibodies in cellular and animal models ofdisease.
Melanie Jambeau, Kevin D Meyer, Marian Hruska-Plochan, Ricardos Tabet, Chao-Zong Lee, Ananya Ray-Soni, Corey Aguilar, Kitty Savage, Nibha Mishra, Nicole Cavegn, Petra ...> ;Proceedings of the National Academy of Sciences of the United States of America. 2022 Dec 6
3 citations
The efficacy of acoustic-based articulatory phenotyping for characterizing and classifying four divergent neurodegenerative diseases using sequential motion rates.
Hannah P Rowe, Perman Gochyyev, Adam C Lammert, Anja Lowit, Kristie A Spencer, Bradford C Dickerson, James D Berry, Jordan R Green> ;Journal of Neural Transmission. 2022 Dec 1
6 citations
Combined Regulatory T-Lymphocyte and IL-2 Treatment Is Safe, Tolerable, and Biologically Active for 1 Year in Persons With Amyotrophic Lateral Sclerosis.
Jason R Thonhoff, James D Berry, Eric A Macklin, David R Beers, Patricia A Mendoza, Weihua Zhao, Aaron D Thome, Fabio Triolo, James J Moon, Sabrina Paganoni, Merit Cud...> ;Neurology(R) Neuroimmunology & Neuroinflammation. 2022 Nov 1
12 citations
Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers: A Review.
Jeremy M Shefner, Richard Bedlack, Jinsy A Andrews, James D Berry, Robert Bowser, Robert Brown, Jonathan D Glass, Nicholas J Maragakis, Timothy M Miller, Jeffrey D Rot...> ;JAMA Neurology. 2022 Dec 1
4 citations
A revision to the United States national ALS registry's algorithm to improve Case-Ascertainment.
Paul Mehta, Jaime Raymond, Moon Han, Reshma Punjani, Theodore Larson, James D Berry, Benjamin Rix Brooks, Björn Oskarsson, Stephen A Goutman, Kevin Horton> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 May 1
7 citations
Rate of speech decline in individuals with amyotrophic lateral sclerosis.
Marziye Eshghi, Yana Yunusova, Kathryn P Connaghan, Bridget J Perry, Marc F Maffei, James D Berry, Lorne Zinman, Sanjay Kalra, Lawrence Korngut, Angela Genge, Annie Di...> ;Scientific Reports. 2022 Sep 20
4 citations
Combination of ciprofloxacin/celecoxib as a novel therapeutic strategy for ALS.
Shiran Salomon-Zimri, Avital Pushett, Niva Russek-Blum, Ruben P A Van Eijk, Nurit Birman, Beatrice Abramovich, Erez Eitan, Katya Elgrart, Danielle Beaulieu, David L En...> ;Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 2023 May 1
Join now to see all

Press Mentions

BrainStorm to Present NurOwn® Phase 3 Clinical Trial Results at 31st International Symposium on ALS/MNDNovember 23rd, 2020
First Patient Enrolled in MTPA REFINE-ALS Biomarker StudyNovember 25th, 2019
Paganoni Advances ALS Research and Care with TechnologyMay 16th, 2018
Join now to see all

Hospital Affiliations

Massachusetts General HospitalBoston, Massachusetts